Board Member and Chief Medical Advisor @ Isosceles Pharmaceuticals, Inc. (www.isoscelespharma.com)
Scientific Advisory Board Member @ Drug Development Institute (DDI) of the James Comprehensive Cancer Center at Ohi
Robert Stein's Education
Duke University Medical & Graduate Schools
M.D.-Ph.D. (Physiology & Pharmacology)
1972 - 1979
Duke University Medical & Graduate Schools
Doctor of Philosophy (Ph.D.) (Physiology & Pharmacology)
1974 - 1978
Indiana University Bloomington
Bachelor of Science (B.S.) (Biology & Chemistry)
1968 - 1972
Duke University Medical & Graduate Schools
HS Diploma (Valedictorian, National Merit Scholar)
1966 - 1968
Robert Stein's Skills
Drug Discovery
Biotechnology
Lifesciences
Clinical Development
Pharmaceutical Industry
Pharmacology
Immunology
Drug Development
Clinical Trials
Molecular Biology
Robert Stein's Summary
Robert Stein, based in New York, NY, US, is currently a President, Regenerative Medicine and Biologics Innovation (Mimedx; www.mimedx.com) at Mimedx, bringing experience from previous roles at Samsara BioCapital (www.samsaracap.com), Protagenic Therapeutics (PTIX; www.protagenic.com), RBS Biotech Consulting, PLLC and Flame Biosciences (www.flame.bio). Robert Stein holds a 1972 - 1979 M.D.-Ph.D. in Physiology & Pharmacology @ Duke University Medical & Graduate Schools. With a robust skill set that includes Drug Discovery, Biotechnology, Lifesciences, Clinical Development, Pharmaceutical Industry and more, Robert Stein contributes valuable insights to the industry. Robert Stein has 5 emails on RocketReach.